Mizuho lowered the firm’s price target on Dentsply Sirona (XRAY) to $18 from $21 and keeps a Neutral rating on the shares following the ...
In a report released on March 11, Steven Valiquette from Mizuho Securities maintained a Hold rating on LifeMD (LFMD – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback